Research

Research at the Department of Urology covers a wide variety of subspecialties. In recent years, one clear focus has been on uro-oncological research, not least because of rapid advances worldwide in drug therapy for tumors that have metastasized. This applies to cancerous tumors of the prostate, kidney, bladder, penis and testicles.

Focus on the patient

As part of our research activities, we can also enable our patients to participate in international studies with promising and innovative therapeutic approaches.

Research focus

We have established various areas of focus in order to further our research activities. These core topics are currently being researched intensively at our clinic by internationally renowned research groups.

Third-party funded projects

Contact

Hutterer Georg

Projects

A phase 2 Randomized Open-Label Study of Oral ODM-201 vs. androgen deprivation therapy (ADT) with LHRH agonists or antagonist in Men with Hormone Naive Prostate Cancer.
A phase 2 Randomized Open-Label Study of Oral darolutamide (ODM-201) vs. androgen deprivation therapy (ADT) with LHRH agonists or antagonist in Men with Hormone Naive Prostate Cancer
Procade: A Multinational, Phase 3, Randomized, Double-Blind, Non-Inferiority, Efficacy and Safety Study of Oral HC-1119 versus Enzalutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
A Phase III Randomized, Open-Label, Multicenter Study to Determine the Efficacy and Safety of Durvalumab in Combination With Tremelimumab and Enfortumab Vedotin or Durvalumab in Combination With Enfortumab Vedotin for Perioperative Treatment in Patients Ineligible for Cisplatin Undergoing Radical Cystectomy for Muscle Invasive Bladder Cancer (VOLGA)
The influence of antidiabetic drugs on benign prostate hyperplasia development and progression- a retrospective study
A Randomized, open-label, Phase 2 Study of Adjuvant Apalutamide or Standard of Care in Subjects with High-risk, Localized or Locally Advanced Prostate Cancer After Radical Prostatectomy
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Crinecerfont (NBI-74788) in Adult Subjects with Classic Congenital Adrenal Hyperplasia, Followed by Open-Label Treatment

Team

Mahdavian Niosha

Conference contributions – Committed to science and continuing education

ÖBAY 2025 – 51st Conference of the Austrian Society of Urology and the Bavarian Urologists Association

Poster: The correlation of metabolic metabolites with image morphological, genetic, and biological markers in suspected prostate cancer, Johannes Mischinger
Poster: Clinically significant tumor histology in primary elective transurethral resection of the bladder, Conrad Leitsmann
Poster: Performance Comparison of the Histolog® Scanner and Frozen Section Analysis During Robot-Assisted Radical Prostatectomy, Lukas Scheipner

Forschungsinitiativen

Zum Wohle der Patient*innen.

Access for employees

Our research achievements

Projects

Research projects conducted at our department

Publications

Scientific publications from our department